Abdominal Wall Fat Research Articles

Cytosolic calcium and insulin resistance in elderly patients with essential hypertension.

We evaluated insulin sensitivity in normotensive (blood pressure, BP, less than 135/85 mm Hg) and hypertensive (BP greater than 160/90 mm Hg) elderly subjects over 65 years old who were stratified as normal weight (body mass index, BMI, less than 27) and obese (BMI greater than 27). Obese hypertensive individuals demonstrated marked hyperinsulinemia (P less than .01) and significantly reduced (P less than .05) submaximally stimulated adipocyte 2-deoxyglucose (2-DOG) uptake (abdominal wall fat biopsy). Normal weight hypertensive subjects also demonstrated higher levels of insulinemia and lower insulin-stimulated 2-DOG uptake than nonobese controls. Adipocyte [Ca2+]i levels were elevated in all elderly subjects compared to young individuals (P less than .01). Basal and maximally stimulated 2-DOG uptake were similar in all groups. One month of therapy with a calcium channel blocker, 10 mg nitrendipine twice daily, reduced blood pressure in the hypertensive subjects, reduced plasma insulin to control values during an oral glucose tolerance test in obese hypertensive individuals (P less than .01), and restored adipocyte 2-DOG uptake at submaximally effective insulin concentration to control values in normal weight and obese hypertensive subjects. In summary, older hypertensive, and particularly older obese hypertensive, patients manifest significant insulin resistance accompanied by elevated levels of [Ca2+]i in their adipocytes.

Pharmacokinetics and tissue penetration of single-dose cefotetan used for antimicrobial prophylaxis in patients undergoing colorectal surgery.

The pharmacokinetics and tissue penetration of cefotetan were studied after a single injection of 2 g given intravenously for antimicrobial prophylaxis to 16 consecutive patients undergoing colorectal surgery. Concentrations in tissue greater than or equal to the MIC for 90% of the main pathogens tested were considered adequate. The elimination half-life at beta phase was 4.6 +/- 1.4 h, the total body clearance was 0.75 +/- 0.19 ml/kg/min, and the volume of distribution was 260 +/- 71 ml/kg. At the time of incision (33 +/- 16 min after the injection), cefotetan concentrations were 14.2 +/- 7 micrograms/g in abdominal-wall fat, 16.4 +/- 1 micrograms/g in epiploic fat, and 163 +/- 62 mg/liter in serum. At the time of surgical anastomosis (151 +/- 54 min), cefotetan concentrations were 33.3 +/- 6 micrograms/g in the colonic wall and 73 +/- 34 mg/liter in serum. Upon closure of the abdomen (216 +/- 76 min), cefotetan concentrations were 6.3 +/- 3 micrograms/g in abdominal-wall fat, 6.1 +/- 4 micrograms/g in epiploic fat, and 64 +/- 38 mg/liter in serum. Cefotetan tissue penetration was 10% into abdominal and epiploic fat and 46% into the colonic wall. Levels in tissue were compared with the MIC for 90% of the most frequently encountered pathogenic germs (Staphylococcus aureus, Bacteroides fragilis, and Escherichia coli). Adequate concentrations in tissue were obtained up to anastomosis but not upon closure. The authors therefore recommend the injection of an additional dose of 1 g before closure in order to ensure optimal efficacy throughout the surgical procedure.

内臓脂肪蓄積と冠動脈狭窄

内臓脂肪蓄積と冠動脈狭窄

Pharmacokinetics and tissue penetration of a single 1,000-milligram, intravenous dose of metronidazole for antibiotic prophylaxis of colorectal surgery

The levels of metronidazole in serum and tissue penetration of metronidazole were studied after prophylactic administration in 11 patients undergoing elective colorectal surgery. A single dose of 1,000 mg given intravenously was administered before surgery. Adequate drug levels in serum (greater than or equal to MIC for 90% of strains tested [MIC90] for Bacteroides fragilis) were found in all patients throughout the procedure. Mean peak (15-min) and last-determined (24-h) metronidazole levels in serum were 28.8 +/- 8 and 4.2 +/- 1.7 mg/liter, respectively. The beta-phase elimination half-life was 9.5 +/- 2.3 h, and the clearance and apparent volume of distribution were 57 +/- 13 ml/min and 0.7 +/- 0.1 liter/kg, respectively. In the colonic wall at surgical anastomosis, tissue metronidazole levels greater than or equal to MIC90 for B. fragilis were found in 91% of patients. In the abdominal wall fat and epiploic fat, tissue metronidazole levels greater than or equal to MIC90 for B. fragilis were found in 40 to 60% of patients at surgical incision and closure. No anaerobic infection occurred during the study.

CT density of mesenteric, retroperitoneal, and subcutaneous fat in cirrhotic patients: comparison with control subjects.

We determined the density in Hounsfield units of the mesenteric, retroperitoneal, and subcutaneous fat on CT scans made in 41 patients with biopsy-proved cirrhosis and compared the results with the density of the fat in these locations in 34 control subjects, in an attempt to quantify changes in fat density in patients with cirrhosis. The mean densities of mesenteric, retroperitoneal, and subcutaneous fat in patients with cirrhosis were -56, -107, and -111 H, respectively. The corresponding mean densities in control subjects were -107, -118, and -124 H. The mean density of mesenteric fat in patients with cirrhosis was 50% greater than that of their subcutaneous fat (p less than .0001), 48% greater than that of their retroperitoneal fat (p less than .0001), and 48% greater than that of the mesenteric fat in control subjects (p less than .0001). The mean density of subcutaneous fat in the anterior abdominal wall in patients with cirrhosis was -96 H compared with -119 H for that in their posterior abdominal wall. The corresponding mean densities in control subjects were -109 and -131 H. Density of subcutaneous fat in the anterior abdominal wall for all subjects (patients and controls) was 18% greater than that of subcutaneous fat in the posterior abdominal wall (p less than .05). In all locations, the statistical trend was for patients with cirrhosis to have higher density fat than did control subjects. These changes in density are thought to represent diffuse fat edema, most prominently in the mesentery because of portal hypertension.

Derivation of Human Microvascular Endothelial Cells for Prosthetic Vascular Graft Seeding

This report summarizes our techniques and experiences deriving microvascular endothelial cells from fat for vascular graft seeding in 17 patients. Microvascular endothelial cells were derived from abdominal wall fat by collagenase incubation. The mean number of cells obtained using the described procedure was 6.83 x 10(5) cells/gram of fat processed. Histologic evaluation of the harvested cells revealed significant numbers of contaminating cell types in addition to Factor VIII-positive microvascular endothelial cells. These cells were seeded onto 6 mm ID PTFE vascular grafts in patients undergoing peripheral vascular arterial revascularization. The mean number of seeded cells was 8.04 x 10(6) cells/graft. Approximately 90 minutes were required to harvest and isolate the microvascular cells from the fat samples. We feel there are significant technical advantages to deriving endothelial cells from microvessels of human fat for vascular graft seeding.

Refinements in the harvesting of abdominal wall fat grafts for frontal sinus obliteration.

The LaryngoscopeVolume 97, Issue 5 p. 638-638 Article Refinements in the harvesting of abdominal wall fat grafts for frontal sinus obliteration†‡ Mark E. Krugman MD, Corresponding Author Mark E. Krugman MD Santa Ana, CA720 N. Tustin Ave., Santa Ana, CA 92705Search for more papers by this author Mark E. Krugman MD, Corresponding Author Mark E. Krugman MD Santa Ana, CA720 N. Tustin Ave., Santa Ana, CA 92705Search for more papers by this author First published: May 1987 https://doi.org/10.1288/00005537-198705000-00020 † Presented at the Meeting of the Western Section of the American Laryngological, Rhinological and Otological Society, Inc., Los Angeles, CA, January 10, 1987. ‡ From the Division of Otolaryngology and Plastic Surgery, University of California, Irvine, CA. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. Volume97, Issue5May 1987Pages 638-638 RelatedInformation

Aflatoxins in human breast milk.

Breast milk from 99 Sudanese mothers was analysed for aflatoxins. Aflatoxins M1 and/or M2 were detected in 37 of the milks. No other aflatoxin was detected. M1 occurred alone in 13 milks, (mean 19.0 pg/ml), M2 in 11 milks (mean 12.2 pg/ml), and in 13 samples both M1 and M2 were detected. There appeared to be a linear relationship between M1 and M2 where both were excreted. No aflatoxin was detected in subcutaneous abdominal wall fat removed during Caesarian section from 15 women, but was present in three out of 14 bloods taken during anaesthesia. The presence of aflatoxins in mothers' milk showed no correlation with duration of lactation, the infants' nutrition, presence of aflatoxin in mothers' blood, or the infant's blood and urine. It is concluded that some Sudanese women excrete aflatoxins in breast-milk at levels similar to or higher than those considered safe in animal milk, for human consumption.